Basic Information
RNALocate ID: | RLID:11003890 |
RNA Symbol: | hsa-miR-374a-3p |
Localization: | Exosome |
RNA Information
RNA Name: | hsa-miR-374a-3p |
RNA ID: | miRBase:MIMAT0004688 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 23663360 |
Tissue/Cell Line: | Plasma |
Method: | Next-generation RNA sequencing |
Description: | Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences). |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID-D:11000661 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells | |
RLID-D:11001533 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-374a-3p | Multiple sclerosis chronic progressive | MNDR-E-MI-45485 |
MNDR | hsa-miR-374a-3p | High-grade serous ovarian carcinoma | MNDR-E-MI-45486 |
MNDR | hsa-miR-374a-3p | Uterine corpus endometrial carcinoma | MNDR-E-MI-45487 |
MNDR | hsa-miR-374a-3p | Lymphoma | MNDR-E-MI-45488 |
MNDR | hsa-miR-374a-3p | Gastric cancer | MNDR-E-MI-45489 |
MNDR | hsa-miR-374a-3p | Alzheimer disease | MNDR-E-MI-45490 |
MNDR | hsa-miR-374a-3p | Huntington disease | MNDR-E-MI-45491 |
MNDR | hsa-miR-374a-3p | Chorea | MNDR-E-MI-45492 |
MNDR | hsa-miR-374a-3p | Parkinson disease | MNDR-E-MI-45493 |
MNDR | hsa-miR-374a-3p | Breast cancer | MNDR-E-MI-45494 |
MNDR | hsa-miR-374a-3p | Rectum adenocarcinoma | MNDR-E-MI-45495 |
MNDR | hsa-miR-374a-3p | Colon cancer | MNDR-E-MI-45496 |
MNDR | hsa-miR-374a-3p | Colon adenocarcinoma | MNDR-E-MI-45497 |
MNDR | hsa-miR-374a-3p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-45498 |
MNDR | hsa-miR-374a-3p | Familial ovarian cancer | MNDR-E-MI-45499 |
MNDR | hsa-miR-374a-3p | Prostate adenocarcinoma | MNDR-E-MI-45500 |
MNDR | hsa-miR-374a-3p | Carcinoma ductal breast | MNDR-E-MI-45501 |
MNDR | hsa-miR-374a-3p | Glioblastoma | MNDR-E-MI-45502 |
MNDR | hsa-miR-374a-3p | Gastric adenocarcinoma | MNDR-E-MI-45503 |
MNDR | hsa-miR-374a-3p | Lung squamous cell carcinoma | MNDR-E-MI-45504 |
MNDR | hsa-miR-374a-3p | Lung adenocarcinoma | MNDR-E-MI-45505 |
MNDR | hsa-miR-374a-3p | Ovarian carcinoma | MNDR-E-MI-45506 |
MNDR | hsa-miR-374a-3p | Bladder urothelial carcinoma | MNDR-E-MI-45507 |
MNDR | hsa-miR-374a-3p | Pancreatic adenocarcinoma | MNDR-E-MI-45508 |
MNDR | hsa-miR-374a-3p | Carcinoma renal cell | MNDR-E-MI-45509 |
MNDR | hsa-miR-374a-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-45510 |
MNDR | hsa-miR-374a-3p | Renal clear cell carcinoma | MNDR-E-MI-45511 |
MNDR | hsa-miR-374a-3p | Testicular germ cell cancer | MNDR-E-MI-45512 |
MNDR | hsa-miR-374a-3p | Breast invasive carcinoma | MNDR-E-MI-45513 |
MNDR | hsa-miR-374a-3p | Hepatocellular carcinoma | MNDR-E-MI-45514 |
MNDR | hsa-miR-374a-3p | Familiar ovarian carcinoma | MNDR-E-MI-45515 |
MNDR | hsa-miR-374a-3p | Rheumatoid arthritis | MNDR-E-MI-45516 |
MNDR | hsa-miR-374a-3p | Colorectal cancer | MNDR-E-MI-45517 |
MNDR | hsa-miR-374a-3p | Epstein-barr virus infections | MNDR-E-MI-45518 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | AXIN2 | Homo sapiens | RR00168697 |
TOP